Genelux Co. (NASDAQ: GNLX) had its price target lowered by analysts at Benchmark Co. from $30.00 to $25.00. They now have a "speculative buy" rating on the stock.
Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants
Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants
Genelux Co. (NASDAQ: GNLX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates